Published in Arch Biochem Biophys on January 01, 1992
A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc Natl Acad Sci U S A (1994) 5.44
Biochemical characterization of the protein tyrosine kinase homology domain of the ErbB3 (HER3) receptor protein. Biochem J (1997) 1.91
In vitro activation of Stat3 by epidermal growth factor receptor kinase. Proc Natl Acad Sci U S A (1996) 1.58
The carboxyl terminus controls ligand-dependent activation of VEGFR-2 and its signaling. J Biol Chem (2003) 0.94
Conformational changes accompany phosphorylation of the epidermal growth factor receptor C-terminal domain. Protein Sci (2005) 0.93
Structure and dynamics of the epidermal growth factor receptor C-terminal phosphorylation domain. Protein Sci (2006) 0.88
Physicochemical characterization of the cytoplasmic domain of the epidermal growth factor receptor and evidence for conformational changes associated with its activation by ammonium sulphate. Biochem J (1995) 0.78
Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics. Nat Cell Biol (1999) 6.18
A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc Natl Acad Sci U S A (1994) 5.44
The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling. J Biol Chem (1997) 4.03
C-kinase phosphorylates the epidermal growth factor receptor and reduces its epidermal growth factor-stimulated tyrosine protein kinase activity. J Biol Chem (1984) 3.88
Requirement for intrinsic protein tyrosine kinase in the immediate and late actions of the EGF receptor. Nature (1987) 3.75
On the mechanism of action of adrenocorticotropic hormone: the binding of cyclic-3',5'-adenosine monophosphate to an adrenal cortical protein. Proc Natl Acad Sci U S A (1969) 3.50
Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature. Medicine (Baltimore) (1980) 3.20
Enhanced degradation of EGF receptors by a sorting nexin, SNX1. Science (1996) 3.20
Functional independence of the epidermal growth factor receptor from a domain required for ligand-induced internalization and calcium regulation. Cell (1989) 3.12
A cyclic-3',5'-adenosine monophosphate dependent protein kinase from the adrenal cortex: comparison with a cyclic AMP binding protein. Biochem Biophys Res Commun (1970) 2.98
Ligand-induced transformation by a noninternalizing epidermal growth factor receptor. Science (1990) 2.92
Increased phosphotyrosine content and inhibition of proliferation in EGF-treated A431 cells. Nature (1981) 2.75
Expression cloning of human EGF receptor complementary DNA: gene amplification and three related messenger RNA products in A431 cells. Science (1984) 2.75
Inhibition of the receptor-binding function of clathrin adaptor protein AP-2 by dominant-negative mutant mu2 subunit and its effects on endocytosis. EMBO J (1999) 2.60
Protein kinase C phosphorylation at Thr 654 of the unoccupied EGF receptor and EGF binding regulate functional receptor loss by independent mechanisms. Cell (1986) 2.31
Nuclear LIM interactor, a rhombotin and LIM homeodomain interacting protein, is expressed early in neuronal development. Proc Natl Acad Sci U S A (1996) 2.29
The role of tyrosine kinase activity in endocytosis, compartmentation, and down-regulation of the epidermal growth factor receptor. J Biol Chem (1991) 2.15
Analysis of deletions of the carboxyl terminus of the epidermal growth factor receptor reveals self-phosphorylation at tyrosine 992 and enhanced in vivo tyrosine phosphorylation of cell substrates. J Biol Chem (1990) 2.13
Ligand-induced endocytosis of the EGF receptor is blocked by mutational inactivation and by microinjection of anti-phosphotyrosine antibodies. Cell (1988) 2.08
The nuclear LIM domain interactor NLI mediates homo- and heterodimerization of LIM domain transcription factors. J Biol Chem (1998) 2.07
RGS-PX1, a GAP for GalphaS and sorting nexin in vesicular trafficking. Science (2001) 2.05
Functional analysis of the nuclear LIM domain interactor NLI. Mol Cell Biol (1997) 2.04
Regulated migration of epidermal growth factor receptor from caveolae. J Biol Chem (1999) 2.03
Protein-protein interaction of zinc finger LIM domains with protein kinase C. J Biol Chem (1996) 1.90
On the mechanism of action of ACTH. Recent Prog Horm Res (1971) 1.81
Immunoaffinity purification of the epidermal growth factor receptor. Stoichiometry of binding and kinetics of self-phosphorylation. J Biol Chem (1984) 1.80
Self-phosphorylation enhances the protein-tyrosine kinase activity of the epidermal growth factor receptor. J Biol Chem (1985) 1.80
Role of the receptor in the mechanism of action of adenosine 3':5'-cyclic monophosphate. Proc Natl Acad Sci U S A (1971) 1.64
Relation of epidermal growth factor receptor concentration to growth of human epidermoid carcinoma A431 cells. J Biol Chem (1984) 1.55
Control of bovine adrenal cortical cell proliferation by fibroblast growth factor. Lack of effect of epidermal growth factor. Endocrinology (1977) 1.53
Structural features that specify tyrosine kinase activity deduced from homology modeling of the epidermal growth factor receptor. Proc Natl Acad Sci U S A (1993) 1.53
Endocytosis and mitogenic signaling. Curr Opin Cell Biol (1999) 1.52
Nucleotide regulation of a eukaryotic protein synthesis initiation complex;. Biochim Biophys Acta (1975) 1.52
Endocytosis and lysosomal targeting of epidermal growth factor receptors are mediated by distinct sequences independent of the tyrosine kinase domain. J Biol Chem (1995) 1.52
Altered epidermal growth factor (EGF)-stimulated protein kinase activity in variant A431 cells with altered growth responses to EGF. Proc Natl Acad Sci U S A (1982) 1.47
LIM domain recognition of a tyrosine-containing tight turn. J Biol Chem (1994) 1.47
Production of an epidermal growth factor receptor-related protein. Science (1984) 1.46
Alteration of epidermal growth factor receptor activity by mutation of its primary carboxyl-terminal site of tyrosine self-phosphorylation. J Biol Chem (1988) 1.46
Interaction between the epidermal growth factor receptor and phosphoinositide kinases. J Biol Chem (1991) 1.40
Hyperglycemia and hyperosmolality complicating peritoneal dialysis. Ann Intern Med (1967) 1.40
Association of epidermal growth factor receptors with coated pit adaptins via a tyrosine phosphorylation-regulated mechanism. J Biol Chem (1995) 1.34
Chip and apterous physically interact to form a functional complex during Drosophila development. Mol Cell (1999) 1.30
Regulation of the ERBB-2 promoter by RBPJkappa and NOTCH. J Biol Chem (1997) 1.30
A site of tyrosine phosphorylation in the C terminus of the epidermal growth factor receptor is required to activate phospholipase C. Mol Cell Biol (1992) 1.29
Ligand-induced endocytosis of epidermal growth factor receptors that are defective in binding adaptor proteins. Proc Natl Acad Sci U S A (1995) 1.28
Structure and function of LIM domains. Curr Top Microbiol Immunol (1998) 1.26
Mitogenic signaling by Ret/ptc2 requires association with enigma via a LIM domain. J Biol Chem (1996) 1.23
Structural features of LIM kinase that control effects on the actin cytoskeleton. J Biol Chem (1999) 1.22
Analysis of morphology and receptor metabolism in clonal variant A431 cells with differing growth responses to epidermal growth factor. J Cell Physiol (1983) 1.22
Activation of the purified protein tyrosine kinase domain of the epidermal growth factor receptor. J Biol Chem (1989) 1.20
Identification and characterization of LMO4, an LMO gene with a novel pattern of expression during embryogenesis. Proc Natl Acad Sci U S A (1998) 1.20
A negative feedback loop attenuates EGF-induced morphological changes. J Cell Biol (1991) 1.18
Mutational removal of the Thr669 and Ser671 phosphorylation sites alters substrate specificity and ligand-induced internalization of the epidermal growth factor receptor. J Biol Chem (1990) 1.17
Epidermal growth factor receptor threonine and serine residues phosphorylated in vivo. J Biol Chem (1988) 1.17
Structural analysis of the transmembrane domain of the epidermal growth factor receptor. J Biol Chem (1991) 1.17
The intracellular tyrosine kinase domain of the epidermal growth factor receptor undergoes a conformational change upon autophosphorylation. J Biol Chem (1994) 1.17
Phosphorylation of ribosome-associated protein by an adenosine 3':5'-cyclic monophosphate-dependent protein kinase: location of the microsomal receptor and protein kinase. Proc Natl Acad Sci U S A (1971) 1.16
Anti-pp60src antibodies are substrates for EGF-stimulated protein kinase. Nature (1981) 1.16
Ligand-activated thyroid hormone and retinoic acid receptors inhibit growth factor receptor promoter expression. Cell (1990) 1.16
Ribonuclease H (hybrid) in Escherichia coli. Identification and characterization. J Biol Chem (1973) 1.15
Phosphorylation of the epidermal growth factor receptor at threonine 654 inhibits ligand-induced internalization and down-regulation. J Biol Chem (1990) 1.14
The LIM-only factor LMO4 regulates expression of the BMP7 gene through an HDAC2-dependent mechanism, and controls cell proliferation and apoptosis of mammary epithelial cells. Oncogene (2007) 1.14
Regulation of ternary (Met-tRNAf - GTP - eukaryotic initiation factor 2) protein synthesis initiation complex formation by the adenylate energy charge. Biochim Biophys Acta (1976) 1.13
Receptor tyrosine kinases. FASEB J (1992) 1.12
The PDZ domain of the LIM protein enigma binds to beta-tropomyosin. Mol Biol Cell (1999) 1.12
Specificity of LIM domain interactions with receptor tyrosine kinases. J Biol Chem (1996) 1.11
Phosphorylation of high mobility group protein 14 by casein kinase II. J Biol Chem (1985) 1.07
Chip is an essential cofactor for apterous in the regulation of axon guidance in Drosophila. Development (2000) 1.06
Angiotensin stimulation of bovine adrenocortical cell growth. Proc Natl Acad Sci U S A (1977) 1.06
Separation and characterization of a phosphatidylinositol kinase activity that co-purifies with the epidermal growth factor receptor. J Biol Chem (1985) 1.05
Epidermal growth factor and its receptor. Mol Cell Endocrinol (1987) 1.04
Assay of cyclic nucleotide-dependent protein kinases. Adv Cyclic Nucleotide Res (1979) 1.03
Ligand-induced internalization and increased cell calcium are mediated via distinct structural elements in the carboxyl terminus of the epidermal growth factor receptor. J Biol Chem (1991) 1.02
Structure and inducible regulation of the human c-erb B2/neu promoter. J Biol Chem (1990) 1.01
Surgical management of the thyroid nodule: patient selection based on the results of fine-needle aspiration cytology. Laryngoscope (1992) 1.00
T3 receptor suppression of Sp1-dependent transcription from the epidermal growth factor receptor promoter via overlapping DNA-binding sites. J Biol Chem (1993) 1.00
Preferential regulation of protein synthesis initiation complex formation by purine nucleotides. Biochim Biophys Acta (1976) 1.00
A three-step purification procedure for protein kinase C: characterization of the purified enzyme. Anal Biochem (1987) 1.00
The product of the MLD gene is a member of the membrane fatty acid desaturase family: overexpression of MLD inhibits EGF receptor biosynthesis. Biochemistry (1997) 0.99
Identity of the in vivo phosphorylation site in high mobility group 14 protein in HeLa cells with the site phosphorylated by casein kinase II in vitro. J Biol Chem (1983) 0.98
Purification and characterization of 3':5'-cyclic GMP-dependent protein kinase. Proc Natl Acad Sci U S A (1976) 0.98
Coexpression of both alpha and beta subunits is required for assembly of regulated casein kinase II. Biochemistry (1991) 0.98
Hormonal control of adrenocortical cell proliferation. Desensitization to ACTH and interaction between ACTH and fibroblast growth factor in bovine adrenocortical cell cultures. J Clin Invest (1977) 0.98
Enhanced tumorigenesis of NR6 cells which express non-down-regulating epidermal growth factor receptors. Cancer Res (1991) 0.97
Effects of epidermal growth factor receptor concentration on tumorigenicity of A431 cells in nude mice. Cancer Res (1986) 0.97
Shc and Enigma are both required for mitogenic signaling by Ret/ptc2. Mol Cell Biol (1998) 0.96
Positive and negative regulatory elements in the human erbB-2 gene promoter. Oncogene (1994) 0.93
The EGF receptor: structure, regulation and potential role in malignancy. Cancer Surv (1985) 0.93
Identification and characterization of a regulated promoter element in the epidermal growth factor receptor gene. Proc Natl Acad Sci U S A (1990) 0.92
Structural analysis of cGMP-dependent protein kinase using limited proteolysis. J Biol Chem (1980) 0.92
Role of epidermal growth factor-stimulated protein kinase in control of proliferation of A431 cells. J Cell Biochem (1982) 0.91
Hormonal control of adrenal RNA polymerase activities. Endocrinology (1974) 0.90
Characterization of adult bovine adrenocortical cells throughout their life span in tissue culture. Endocrinology (1978) 0.90
Phosphorylation of high mobility group 14 protein by cyclic nucleotide-dependent protein kinases. J Biol Chem (1982) 0.89
Regulation of cyclic nucleotide-dependent protein kinase activity by histones and poly(L-arginine). J Biol Chem (1981) 0.88
Direct binding of eps8 to the juxtamembrane domain of EGFR is phosphotyrosine- and SH2-independent. Oncogene (1995) 0.88
Regulation of the epidermal growth factor receptor by phosphorylation. J Cell Biochem (1985) 0.87
Guanosine 3':5'-monophosphate-dependent protein kinase from bovine lung. Subunit structure and characterization of the purified enzyme. J Biol Chem (1977) 0.87
Relationship between production of epidermal growth factor receptors, gene amplification, and chromosome 7 translocation in variant A431 cells. Somat Cell Mol Genet (1985) 0.87